跳至主要内容

Ancient Gut Genetic Core Program Finding May Lead to New Digestive Disease Therapies

 Scientists from the Duke University School of Medicine have discovered a network of genes and genetic regulatory elements in the lining of the intestines that has stayed remarkably the same from fishes to humans. Many of these genes are linked to human illnesses, such as inflammatory bowel diseases, diabetes and obesity.

Medicilon can provide various animal models (including renal failure model, anemia animal model, gastric acid secretion animal model, and gastric ulcer model) to test drug effectiveness according to client needs. We can conduct tests on typical digestive system diseases, including gastric acid secretions, gastric ulcers, and renal failure, using rats as subjects.

The research (“Genomic Dissection of Conserved Transcriptional Regulation in Intestinal Epithelial Cells”), which appears in PLOS Biology, marks fish as a model organism for studying how this old genetic information (covering over 420 million years of evolution) controls the development and dysfunction of the intestine.

“The intestinal epithelium serves critical physiologic functions that are shared among all vertebrates. However, it is unknown how the transcriptional regulatory mechanisms underlying these functions have changed over the course of vertebrate evolution. We generated genome-wide mRNA and accessible chromatin data from adult intestinal epithelial cells (IECs) in zebrafish, stickleback, mouse, and human species to determine if conserved IEC functions are achieved through common transcriptional regulation. We found evidence for substantial common regulation and conservation of gene expression regionally along the length of the intestine from fish to mammals and identified a core set of genes comprising a vertebrate IEC signature,” write the investigators.

“We define an IEC transcriptional regulatory network that is shared between fish and mammals and establish an experimental platform for studying how evolutionarily distilled regulatory information commonly controls IEC development and physiology.”

“Our research has uncovered aspects of intestinal biology that have been well conserved during vertebrate evolution, suggesting they are of central importance to intestinal health,” said John F. Rawls, Ph.D., senior author of the study and associate professor of molecular genetics and microbiology. “By doing so, we have built a foundation for mechanistic studies of intestinal biology in nonhuman model systems like fish and mice that would be impossible to perform in humans alone.”

According to Dr. Rawls, researchers for years have used animal models to collect information on intestinal epithelial cells that could help combat human diseases. But no one knew how alike these cells were across multiple species. He and colleagues took a comparative biology approach to address this issue.

Research associate Colin R. Lickwar, Ph.D., and the team obtained genome-wide data from intestinal epithelial cells in four species: zebrafish, stickleback fish, mouse, and human. Dr. Lickwar then created maps for each of the species that showed both the activity level of all of the genes and the location of specific regulatory elements that turned the genes on and off.

The group found a surprising amount of similarity between the different vertebrate species. Dr. Lickwar identified a common set of genes—labeled an intestinal epithelial cell signature—some of which had shared patterns of activity in specific regions along the length of the intestine. Many of these genes had previously been implicated in a variety of human diseases, and Drs. Lickwar and Rawls wanted to know if this conserved genetic signature was controlled by regulatory elements that might also be shared between species.

They took regulatory elements from fish, mice, and humans and put them into the zebrafish, which are transparent organisms. The scientists then looked under the microscope for color patterns to tell whether a green fluorescent protein or red fluorescent protein, which they had inserted along with the regulatory element, had been turned on in the intestine. They found that this was the case, indicating a very high level of conservation.

“Our findings suggest that intestinal epithelial cells use an ancient core program to do their job in the body of most vertebrates,” said Dr. Lickwar, who is lead author of the study. “Now that we have identified this core program, we can more easily translate results back and forth between humans and zebrafish.”

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati